Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 111

1.

Surgical Treatment of a High-Flow Femoro-Femoral Arteriovenous Fistula in an Intravenous Drug Abuser.

Rossetti P, Perini P, Ucci A, Carolla G, Freyrie A, Quintavalla R.

Ann Vasc Surg. 2018 Jun 7. pii: S0890-5096(18)30331-5. doi: 10.1016/j.avsg.2018.02.051. [Epub ahead of print]

PMID:
29772331
2.

Early and mid-term results in the endovascular treatment of popliteal aneurysms with the multilayer flow modulator.

Ucci A, Curci R, Azzarone M, Bianchini Massoni C, Bozzani A, Marcato C, Marone EM, Perini P, Tecchio T, Freyrie A, Argenteri A.

Vascular. 2018 Jan 1:1708538118771258. doi: 10.1177/1708538118771258. [Epub ahead of print]

PMID:
29665749
3.

One-year experience in carotid endarterectomy combining general anaesthesia with preserved consciousness and sequential carotid cross-clamping.

Ucci A, D'Ospina RM, Fanelli M, Rossi G, Persi F, Bridelli F, Tosi M, Bianchini Massoni C, Perini P, Nabulsi B, De Troia A, Tecchio T, Azzarone M, Freyrie A.

Acta Biomed. 2018 Mar 27;89(1):61-66. doi: 10.23750/abm.v89i1.6814.

PMID:
29633744
4.

Decreased platelet number in multiple sclerosis during alemtuzumab infusion: a common, transient and clinically silent phenomenon.

Puthenparampil M, Rinaldi F, Federle L, Cazzola C, Perini P, Gallo P.

Ther Adv Neurol Disord. 2017 Nov 29;11:1756285617741056. doi: 10.1177/1756285617741056. eCollection 2018.

5.

Evidence of B-cell dysregulation in severe CNS inflammation after alemtuzumab therapy.

Rinaldi F, Federle L, Puthenparampil M, Perini P, Grassivaro F, Gallo P.

Neurol Neuroimmunol Neuroinflamm. 2017 Dec 13;5(1):e420. doi: 10.1212/NXI.0000000000000420. eCollection 2018 Jan. No abstract available.

6.

Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis.

Puthenparampil M, Federle L, Poggiali D, Miante S, Signori A, Pilotto E, Rinaldi F, Perini P, Sormani MP, Midena E, Gallo P.

PLoS One. 2017 Aug 29;12(8):e0183957. doi: 10.1371/journal.pone.0183957. eCollection 2017.

7.

A systematic review of treatment modalities and outcomes of type Ib endoleak after endovascular abdominal aneurysm repair.

Bianchini Massoni C, Perini P, Tecchio T, Azzarone M, de Troia A, Freyrie A.

Vascular. 2018 Feb;26(1):90-98. doi: 10.1177/1708538117726468. Epub 2017 Aug 17. Review.

PMID:
28814153
8.

Acute simultaneous development of brain tumour-like lesion and demyelinating polyneuropathy in a patient with chronic relapsing myelitis.

Puthenparampil M, Terrin A, Federle L, Gizzi M, Perini P, Gallo P.

Mult Scler. 2018 Apr;24(4):546-550. doi: 10.1177/1352458517714610. Epub 2017 Aug 10.

PMID:
28795610
9.

Use of a Thoracic Endograft in an Acute Abdominal Aortic Setting: Case Report and Literature Review.

Tasselli S, Perini P, Paini E, Milan L, Bonvini S.

Vasc Endovascular Surg. 2017 Oct;51(7):493-497. doi: 10.1177/1538574417718446. Epub 2017 Jul 26. Review.

PMID:
28743219
10.

Routine Shunting During Carotid Endarterectomy in Patients With Acute Watershed Stroke.

Perini P, Bonifati DM, Tasselli S, Sogaro F.

Vasc Endovascular Surg. 2017 Jul;51(5):288-294. doi: 10.1177/1538574417708130. Epub 2017 May 14.

PMID:
28504077
11.

Perioperative and Late Outcomes after Endovascular Treatment for Isolated Iliac Artery Aneurysms.

Bianchini Massoni C, Freyrie A, Gargiulo M, Tecchio T, Mascoli C, Gallitto E, Faggioli G, Pini R, Azzarone M, Perini P, Stella A.

Ann Vasc Surg. 2017 Oct;44:83-93. doi: 10.1016/j.avsg.2017.03.194. Epub 2017 May 4.

PMID:
28479466
12.

Infrarenal endograft clamping in late open conversions after endovascular abdominal aneurysm repair.

Perini P, de Troia A, Tecchio T, Azzarone M, Bianchini Massoni C, Salcuni P, Freyrie A.

J Vasc Surg. 2017 Oct;66(4):1048-1055. doi: 10.1016/j.jvs.2017.01.057. Epub 2017 Apr 11.

PMID:
28410923
13.

Endovascular Management of Para-prosthetic Aortocaval Fistula: Case Report and Systematic Review of the Literature.

Bianchini Massoni C, Rossi G, Tecchio T, Perini P, Freyrie A.

Ann Vasc Surg. 2017 Apr;40:300.e1-300.e9. doi: 10.1016/j.avsg.2016.08.042. Epub 2017 Feb 3. Review.

PMID:
28163172
14.

BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset.

Puthenparampil M, Federle L, Miante S, Zito A, Toffanin E, Ruggero S, Ermani M, Pravato S, Poggiali D, Perini P, Rinaldi F, Gallo P.

J Neuroinflammation. 2017 Jan 17;14(1):11. doi: 10.1186/s12974-016-0785-2.

15.

Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study.

Annovazzi P, Capobianco M, Moiola L, Patti F, Frau J, Uccelli A, Centonze D, Perini P, Tortorella C, Prosperini L, Lus G, Fuiani A, Falcini M, Martinelli V, Comi G, Ghezzi A.

J Neurol. 2016 Sep;263(9):1727-35. doi: 10.1007/s00415-016-8188-y. Epub 2016 Jun 10.

PMID:
27286847
16.

Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study.

Paolicelli D, Cocco E, Di Lecce V, Direnzo V, Moiola L, Lanzillo R, Perini P, Malucchi S, Borriello G, Portaccio E, Panetta V, Fenu G, Sangalli F, Cacciaguerra L, Trojano M; TRACER Group.

Expert Opin Drug Deliv. 2016 Jun;13(6):799-805. doi: 10.1517/17425247.2016.1158161. Epub 2016 Mar 12.

PMID:
26922837
17.

A case of relapsing-remitting tumour-like inflammation of the central nervous system.

Miante S, Perini P, Rinaldi F, Gallo P.

Mult Scler. 2015 Nov;21(13):1742-5. doi: 10.1177/1352458515599076. Epub 2015 Sep 11.

PMID:
26362889
18.

MRI-detectable cortical lesions in the cerebellum and their clinical relevance in multiple sclerosis.

Favaretto A, Lazzarotto A, Poggiali D, Rolma G, Causin F, Rinaldi F, Perini P, Gallo P.

Mult Scler. 2016 Apr;22(4):494-501. doi: 10.1177/1352458515594043. Epub 2015 Jul 10.

PMID:
26163070
19.

In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib.

Redaelli S, Perini P, Ceccon M, Piazza R, Rigolio R, Mauri M, Boschelli F, Giannoudis A, Gambacorti-Passerini C.

J Hematol Oncol. 2015 Jul 7;8:81. doi: 10.1186/s13045-015-0179-4.

20.

Disease-modifying drugs reduce cortical lesion accumulation and atrophy progression in relapsing-remitting multiple sclerosis: results from a 48-month extension study.

Rinaldi F, Perini P, Atzori M, Favaretto A, Seppi D, Gallo P.

Mult Scler Int. 2015;2015:369348. doi: 10.1155/2015/369348. Epub 2015 Feb 23.

Supplemental Content

Loading ...
Support Center